{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:21:39Z","timestamp":1707524499421},"reference-count":35,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,12]]},"DOI":"10.7759\/cureus.20358","type":"journal-article","created":{"date-parts":[[2021,12,12]],"date-time":"2021-12-12T15:27:25Z","timestamp":1639322845000},"source":"Crossref","is-referenced-by-count":0,"title":["Monitoring Pharmacological Treatment in Patients With Chronic Noncancer Pain"],"prefix":"10.7759","author":[{"given":"Grisell","family":"Vargas-Schaffer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen","family":"Steverman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronique","family":"Potvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1155\/2002\/323085","article-title":"Chronic pain in Canada--prevalence, treatment, impact and the role of opioid analgesia","volume":"7","author":"Moulin DE","year":"2002","unstructured":"Moulin DE, Clark AJ, Speechley M, Morley-Forster PK. Chronic pain in Canada--prevalence, treatment, impact and the role of opioid analgesia. Pain Res Manag. 2002, 7:179-84. 10.1155\/2002\/323085","journal-title":"Pain Res Manag"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/00002508-199309000-00004","article-title":"Chronic pain in a geographically defined general population: studies of differences in age, gender, social class, and pain localization","volume":"9","author":"Andersson HI","year":"1993","unstructured":"Andersson HI, Ejlertsson G, Leden I, Rosenberg C. Chronic pain in a geographically defined general population: studies of differences in age, gender, social class, and pain localization. Clin J Pain. 1993, 9:174-82. 10.1097\/00002508-199309000-00004","journal-title":"Clin J Pain"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2005.06.009","article-title":"Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment","volume":"10","author":"Breivik H","year":"2006","unstructured":"Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006, 10:287-333. 10.1016\/j.ejpain.2005.06.009","journal-title":"Eur J Pain"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/papr.12132","article-title":"Prevalence of chronic pain, impact on daily life, and treatment practices in India","volume":"14","author":"Dureja GP","year":"2014","unstructured":"Dureja GP, Jain PN, Shetty N, et al.. Prevalence of chronic pain, impact on daily life, and treatment practices in India. Pain Pract. 2014, 14:E51-62. 10.1111\/papr.12132","journal-title":"Pain Pract"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2011.09.012","article-title":"The Declaration Montreal: access to pain management is a fundamental human right","volume":"152","author":"Cousins MJ","year":"2011","unstructured":"Cousins MJ, Lynch ME. The Declaration Montreal: access to pain management is a fundamental human right. Pain. 2011, 152:2673-4. 10.1016\/j.pain.2011.09.012","journal-title":"Pain"},{"key":"ref6","article-title":"Patient therapeutic education. Placing the patient at the centre of the WHO analgesic ladder","volume":"60","author":"Vargas-Schaffer G and Cogan J","unstructured":"Vargas-Schaffer G and Cogan J. Patient therapeutic education. Placing the patient at the centre of the WHO analgesic ladder. Cannadian Family Phisicians. Vol. 60:235-41.","journal-title":"Cannadian Family Phisicians. Vol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000902","article-title":"Multimodal pain therapy in chronic noncancer pain-gold standard or need for further clarification?","volume":"158","author":"Kaiser U","year":"2017","unstructured":"Kaiser U, Treede RD, Sabatowski R. Multimodal pain therapy in chronic noncancer pain-gold standard or need for further clarification?. Pain. 2017, 158:1853-9. 10.1097\/j.pain.0000000000000902","journal-title":"Pain"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S178910","article-title":"Multimodal approaches and tailored therapies for pain management: the trolley analgesic model","volume":"12","author":"Cuomo A","year":"2019","unstructured":"Cuomo A, Bimonte S, Forte CA, Botti G, Cascella M. Multimodal approaches and tailored therapies for pain management: the trolley analgesic model. J Pain Res. 2019, 12:711-4. 10.2147\/JPR.S178910","journal-title":"J Pain Res"},{"key":"ref9","article-title":"Etiologic factors of hyposalivation and consequences for oral health","volume":"41","author":"Wolgin M","year":"2010","unstructured":"Wolgin M, Pischon N, Kielbassa AM. Etiologic factors of hyposalivation and consequences for oral health. Quintessence Int. 2010, 41:321-33.","journal-title":"Quintessence Int"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1111\/j.1360-0443.1996.tb03601.x","article-title":"High sugar intake in a group of women on methadone maintenance in South Western Sydney, Australia","volume":"91","author":"Zador D","year":"1996","unstructured":"Zador D, Lyons Wall PM, Webster I. High sugar intake in a group of women on methadone maintenance in South Western Sydney, Australia. Addiction. 1996, 91:1053-61.","journal-title":"Addiction"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200363070-00003","article-title":"Opioid-induced bowel dysfunction: pathophysiology and potential new therapies","volume":"63","author":"Kurz A","year":"2003","unstructured":"Kurz A, Sessler DI. Opioid-induced bowel dysfunction: pathophysiology and potential new therapies. Drugs. 2003, 63:649-71. 10.2165\/00003495-200363070-00003","journal-title":"Drugs"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1111\/pme.12915","article-title":"Cardiac effects of opioid therapy","volume":"16","author":"Chen A","year":"2015","unstructured":"Chen A, Ashburn MA. Cardiac effects of opioid therapy. Pain Med. 2015, 16:27.","journal-title":"Pain Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.2169","article-title":"Persistent bradycardia with the long-term use of phenytoin and oxycodone: first case report","volume":"10","author":"Syed IA","year":"2018","unstructured":"Syed IA, Kuzel AR, Lodhi MU, Chowdhury W, Rahim U, Rahim M. Persistent bradycardia with the long-term use of phenytoin and oxycodone: first case report. Cureus. 2018, 10:e2169. 10.7759\/cureus.2169","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.11m01326","article-title":"A Review of Potential Adverse Effects of Long-Term Opioid Therapy: A Practitioner's Guide","volume":"14","author":"Baldini A","year":"2012","unstructured":"Baldini A, Von Korff M, Lin EH. A Review of Potential Adverse Effects of Long-Term Opioid Therapy: A Practitioner's Guide. Prim Care Companion CNS Disord. 2012, 14:10.4088\/PCC.11m01326","journal-title":"Prim Care Companion CNS Disord"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/SMJ.0b013e318206f6d3","article-title":"Prolonged sinus pauses with hydromorphone in the absence of cardiac conduction disease","volume":"104","author":"Snarr BS","year":"2011","unstructured":"Snarr BS, Rowley CP, Phan SV, Achanti A, Hendrix GH. Prolonged sinus pauses with hydromorphone in the absence of cardiac conduction disease. South Med J. 2011, 104:239-40. 10.1097\/SMJ.0b013e318206f6d3","journal-title":"South Med J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1159\/000492616","article-title":"Opioids and cardiac arrhythmia: a literature review","volume":"27","author":"Behzadi M","year":"2018","unstructured":"Behzadi M, Joukar S, Beik A. Opioids and cardiac arrhythmia: a literature review. Med Princ Pract. 2018, 27:401-14. 10.1159\/000492616","journal-title":"Med Princ Pract"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-016-0579-3","article-title":"Drug interaction and serotonin toxicity with opioid use: another reason to avoid opioids in headache and migraine treatment","volume":"20","author":"Ansari H","year":"2016","unstructured":"Ansari H, Kouti L. Drug interaction and serotonin toxicity with opioid use: another reason to avoid opioids in headache and migraine treatment. Curr Pain Headache Rep. 2016, 20:50. 10.1007\/s11916-016-0579-3","journal-title":"Curr Pain Headache Rep"},{"key":"ref18","unstructured":"Recommendations on Chronic Pain Practice during the COVID-19 Pandemic. (2020). Accessed. March 27, 2020: https:\/\/www.cureus.com\/publish\/articles\/73578-monitoring-pharmacological-treatment-in-patients-with-chronic-noncancer...."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-019-00543-8","article-title":"The influence of antidepressants on the immune system","volume":"67","author":"Sza\u0142ach \u0141P","year":"2019","unstructured":"Sza\u0142ach \u0141P, Lisowska KA, Cuba\u0142a WJ. The influence of antidepressants on the immune system. Arch Immunol Ther Exp (Warsz). 2019, 67:143-51. 10.1007\/s00005-019-00543-8","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12910","article-title":"Opioid therapy and sleep disorders: risks and mitigation strategies","volume":"16 Suppl 1","author":"Cheatle MD","year":"2015","unstructured":"Cheatle MD, Webster LR. Opioid therapy and sleep disorders: risks and mitigation strategies. Pain Med. 2015, 16 Suppl 1:S22-6. 10.1111\/pme.12910","journal-title":"Pain Med"},{"key":"ref21","article-title":"Opioid-induced respiratory effects: new data on buprenorphine","volume":"20","author":"Albert D","year":"2006","unstructured":"Albert D. Opioid-induced respiratory effects: new data on buprenorphine. Palliative Med. 2006, 20:3.","journal-title":"Palliative Med"},{"key":"ref22","article-title":"Opioid-induced androgen deficiency (OPIAD)","volume":"15","author":"Howard S. Smith","year":"2012","unstructured":"Howard S. Smith, and Jennifer A. Elliott. . Opioid-induced androgen deficiency (OPIAD). Pain Phys. 2012, 15:145-56.","journal-title":"Pain Phys"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(14)70081-6","article-title":"Treatment of hypopituitarism in patients receiving antiepileptic","volume":"3","author":"Paragliola RM","year":"2015","unstructured":"Paragliola RM, Prete A, Kaplan PW, Corsello SM, Salvatori R. Treatment of hypopituitarism in patients receiving antiepileptic. Lancet Diabetes Endocrinol. 2015, 3:132-40. 10.1016\/S2213-8587(14)70081-6","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref24","article-title":"WHO Library Cataloguing-in-Publication Data Mental health action plan 2013-2020","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. WHO Library Cataloguing-in-Publication Data Mental health action plan 2013-2020. WHO, Geneva; 2013."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001133","article-title":"Pain as a risk factor for common mental disorders. Results from the Netherlands Mental Health Survey and Incidence Study-2: a longitudinal, population-based study","volume":"159","author":"de Heer EW","year":"2018","unstructured":"de Heer EW, Have MT, van Marwijk HW, Dekker J, de Graaf R, Beekman AT, van der Feltz-Cornelis CM. Pain as a risk factor for common mental disorders. Results from the Netherlands Mental Health Survey and Incidence Study-2: a longitudinal, population-based study. Pain. 2018, 159:712-8. 10.1097\/j.pain.0000000000001133","journal-title":"Pain"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291708003309","article-title":"The prevalence and workplace costs of adult attention deficit hyperactivity disorder in a large manufacturing firm","volume":"39","author":"Kessler RC","year":"2009","unstructured":"Kessler RC, Lane M, Stang PE, Van Brunt DL. The prevalence and workplace costs of adult attention deficit hyperactivity disorder in a large manufacturing firm. Psychol Med. 2009, 39:137-47. 10.1017\/S0033291708003309","journal-title":"Psychol Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.3554","article-title":"Prescription opioid use and risk for major depressive disorder and anxiety and stress-related disorders: a multivariable Mendelian randomization analysis","volume":"78","author":"Rosoff DB","year":"2021","unstructured":"Rosoff DB, Smith GD, Lohoff FW. Prescription opioid use and risk for major depressive disorder and anxiety and stress-related disorders: a multivariable Mendelian randomization analysis. JAMA Psychiatry. 2021, 78:151-60. 10.1001\/jamapsychiatry.2020.3554","journal-title":"JAMA Psychiatry"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/papr.12129","article-title":"Alterations in pain response are partially reversed by methylphenidate (Ritalin) in adults with attention deficit hyperactivity disorder (ADHD)","volume":"15","author":"Treister R","year":"2015","unstructured":"Treister R, Eisenberg E, Demeter N, Pud D. Alterations in pain response are partially reversed by methylphenidate (Ritalin) in adults with attention deficit hyperactivity disorder (ADHD). Pain Pract. 2015, 15:4-11. 10.1111\/papr.12129","journal-title":"Pain Pract"},{"key":"ref29","doi-asserted-by":"crossref","DOI":"10.1093\/pm\/pnw338","article-title":"Attitudes toward opioids and risk of misuse\/abuse in patients with chronic noncancer pain receiving long-term opioid therapy","volume":"19","author":"Vargas-Schaffer G","year":"2018","unstructured":"Vargas-Schaffer G, Cogan J. Attitudes toward opioids and risk of misuse\/abuse in patients with chronic noncancer pain receiving long-term opioid therapy. Pain Med. 2018, 19:319-27.","journal-title":"Pain Med"},{"key":"ref30","article-title":"The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain","author":"Center PNE-bP","year":"2014","unstructured":"Center PNE-bP. The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain. Agency for Healthcare Research and Quality, Seattle, WA; 2014."},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.2156","article-title":"What are we treating with long-term opioid therapy?","volume":"172","author":"Sullivan MD","year":"2012","unstructured":"Sullivan MD, Ballantyne JC. What are we treating with long-term opioid therapy?. Arch Intern Med. 2012, 172:433-4. 10.1001\/archinternmed.2011.2156","journal-title":"Arch Intern Med"},{"key":"ref32","article-title":"Global action plan on physical activity 2018-2030: more active people for a healthier world","author":"World Health Organization","unstructured":"World Health Organization. Global action plan on physical activity 2018-2030: more active people for a healthier world. World Health Organization, Geneva;"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210418","article-title":"Exercise-induced hypoalgesia: a meta-analysis of exercise dosing for the treatment of chronic pain","volume":"14","author":"Polaski AM","year":"2019","unstructured":"Polaski AM, Phelps AL, Kostek MC, Szucs KA, Kolber BJ. Exercise-induced hypoalgesia: a meta-analysis of exercise dosing for the treatment of chronic pain. PLoS One. 2019, 14:e0210418. 10.1371\/journal.pone.0210418","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011279.pub3","article-title":"Physical activity and exercise for chronic pain in adults: an overview of","volume":"4","author":"Geneen LJ","year":"2017","unstructured":"Geneen LJ, Moore RA, Clarke C, Martin D, Colvin LA, Smith BH. Physical activity and exercise for chronic pain in adults: an overview of. Cochrane Rev. 2017, 4:011279-10. 10.1002\/14651858.CD011279.pub3","journal-title":"Cochrane Rev"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2015.04.022","article-title":"Physical exercise as non-pharmacological treatment of chronic pain: why and when","volume":"29","author":"Ambrose KR","year":"2015","unstructured":"Ambrose KR, Golightly YM. Physical exercise as non-pharmacological treatment of chronic pain: why and when. Best Pract Res Clin Rheumatol. 2015, 29:120-30. 10.1016\/j.berh.2015.04.022","journal-title":"Best Pract Res Clin Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/73578-monitoring-pharmacological-treatment-in-patients-with-chronic-noncancer-pain","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:55Z","timestamp":1707507235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/73578-monitoring-pharmacological-treatment-in-patients-with-chronic-noncancer-pain"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,12]]},"references-count":35,"URL":"https:\/\/doi.org\/10.7759\/cureus.20358","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,12]]}}}